Biogen Inc. joined a consortium to build a collection of biological and medical data, where the company’s employees who had tested for and recovered from the coronavirus would be able to participate.
A recap of business developments from life sciences companies around the world, including U.K.-based Vaccitech Limited and the University of Oxford touting positive safety and efficacy trends in a mid-stage prostate cancer study.
In January 2018, it was announced that five healthcare systems were launching a not-for-profit generic drug company. That company now has a name, Civica Rx.
Pfizer Inc. signed an agreement with Allogene Therapeutics, a company formed by a consortium in which the drugmaker will hold a 25 percent stake, to further develop its allogenic CAR T cell therapy.